Meritage Portfolio Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-62,599
| Closed | -$4.99M | – | 337 |
|
|
2024
Q1 | $4.99M | Sell |
62,599
-3,723
| -6% | -$284K | 0.32% | 99 |
|
|
2023
Q4 | $5.24M | Buy |
66,322
+15,548
| +31% | +$1.11M | 0.35% | 90 |
|
|
2023
Q3 | $3.54M | Buy |
+50,774
| New | +$3.6M | 0.26% | 124 |
|
|
2023
Q2 | – | Sell |
-58,887
| Closed | -$4.38M | – | 347 |
|
|
2023
Q1 | $4.38M | Buy |
+58,887
| New | +$4.94M | 0.33% | 108 |
|
|
2021
Q3 | – | Sell |
-28,018
| Closed | -$2.34M | – | 323 |
|
|
2021
Q2 | $2.34M | Sell |
28,018
-23,565
| -46% | -$1.93M | 0.14% | 164 |
|
|
2021
Q1 | $3.88M | Sell |
51,583
-4,645
| -8% | -$338K | 0.26% | 120 |
|
|
2020
Q4 | $3.84M | Sell |
56,228
-1,548
| -3% | -$101K | 0.28% | 85 |
|
|
2020
Q3 | $3.37M | Sell |
57,776
-6,176
| -10% | -$384K | 0.3% | 81 |
|
|
2020
Q2 | $4.16M | Sell |
63,952
-7,776
| -11% | -$490K | 0.4% | 62 |
|
|
2020
Q1 | $4.26M | Sell |
71,728
-256
| -0.4% | -$17.1K | 0.58% | 48 |
|
|
2019
Q4 | $5.35M | Buy |
71,984
+1,326
| +2% | +$93.1K | 0.47% | 57 |
|
|
2019
Q3 | $4.46M | Buy |
70,658
+1,533
| +2% | +$90.8K | 0.42% | 67 |
|
|
2019
Q2 | $3.77M | Buy |
69,125
+215
| +0.3% | +$11.6K | 0.38% | 99 |
|
|
2019
Q1 | $3.72M | Buy |
+68,910
| New | +$4.25M | 0.38% | 116 |
|
|
2017
Q2 | – | Sell |
-36,183
| Closed | -$2.84M | – | 200 |
|
|
2017
Q1 | $2.84M | Sell |
36,183
-49,863
| -58% | -$3.98M | 0.3% | 134 |
|
|
2016
Q4 | $6.79M | Buy |
86,046
+25,415
| +42% | +$2.06M | 0.74% | 39 |
|
|
2016
Q3 | $5.4M | Sell |
60,631
-1,943
| -3% | -$183K | 0.59% | 67 |
|
|
2016
Q2 | $5.99M | Sell |
62,574
-1,200
| -2% | -$120K | 0.67% | 45 |
|
|
2016
Q1 | $6.62M | Sell |
63,774
-875
| -1% | -$85.1K | 0.75% | 37 |
|
|
2015
Q4 | $6.32M | Sell |
64,649
-678
| -1% | -$66.4K | 0.71% | 39 |
|
|
2015
Q3 | $6.3M | Buy |
65,327
+857
| +1% | +$90.1K | 0.73% | 35 |
|
|
2015
Q2 | $6.76M | Buy |
64,470
+65
| +0.1% | +$6.64K | 0.71% | 30 |
|
|
2015
Q1 | $6.65M | Buy |
64,405
+510
| +0.8% | +$51.6K | 0.67% | 39 |
|
|
2014
Q4 | $6.15M | Sell |
63,895
-1,695
| -3% | -$149K | 0.65% | 39 |
|
|
2014
Q3 | $5.22M | Sell |
65,590
-579
| -0.9% | -$45.6K | 0.59% | 67 |
|
|
2014
Q2 | $4.99M | Sell |
66,169
-34,424
| -34% | -$2.6M | 0.54% | 79 |
|
|
2014
Q1 | $7.53M | Buy |
100,593
+2,310
| +2% | +$163K | 0.9% | 14 |
|
|
2013
Q4 | $7.03M | Sell |
98,283
-5,073
| -5% | -$326K | 0.87% | 16 |
|
|
2013
Q3 | $5.87M | Buy |
103,356
+971
| +0.9% | +$57.9K | 0.76% | 32 |
|
|
2013
Q2 | $5.85M | Buy |
+102,385
| New | +$5.93M | 0.84% | 21 |
|
Other funds holding CVS
Meritage Portfolio Management's CVS Position: Q2 2024 in Review
Meritage Portfolio Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 62,599 shares — an estimated $4.99M sold.
Meritage Portfolio Management first reported a position in CVS in Q2 2013 and held it in 30 quarters. The position peaked at $7.53M in Q1 2014. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Meritage Portfolio Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Meritage Portfolio Management sold 62,599 CVS Health shares in Q2 2024, an estimated $4.99M.
- Meritage Portfolio Management first reported a position in CVS Health in Q2 2013 and held it in 30 quarters.
- Meritage Portfolio Management's CVS Health position peaked at $7.53M in Q1 2014.
- 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Meritage Portfolio Management's 13F filing for Q2 2024, filed 9 Aug 2024.